Editorial Policy
Everyday Peptides is committed to providing accurate, research-backed, and medically reviewed peptide education. This policy explains how we create, review, and maintain our content.
How We Research
All health-related claims in our content must be supported by peer-reviewed scientific literature. Our primary sources include PubMed-indexed journals, FDA documents, clinical trial registries (ClinicalTrials.gov), and university research publications.
We prioritize randomized controlled trials and systematic reviews when available. When evidence is limited to animal studies or in vitro research, we explicitly state this limitation so readers can assess the evidence level for themselves.
How We Write
Our articles are written by credentialed experts in peptide biochemistry, pharmacology, and related fields. Every article follows an answer-first writing format, leading with direct answers before expanding with context and evidence.
We target a readability level of grade 8-10 on the Flesch-Kincaid scale, using plain language to make complex science accessible without sacrificing accuracy. Technical terms are defined on first use and linked to our glossary.
Medical Review Process
Every article is reviewed by a qualified medical professional before publication. Our medical reviewers hold MD, PhD, PharmD, or equivalent credentials in relevant specialties. The reviewer's name, credentials, and review date are displayed on every article.
Medical reviewers verify the accuracy of health claims, appropriateness of dosing information, completeness of safety warnings, and overall clinical relevance of the content.
How We Update Content
We review and update every article at least quarterly. When significant new research is published, we update relevant articles within one week. Every article displays a "Last Updated" date so readers always know when the information was last verified.
Our content monitoring process includes automated PubMed alerts for key peptide topics, manual review of major journal publications, and tracking of FDA regulatory announcements.
What We Will Not Do
- Claim a peptide "cures" or "treats" a condition unless it has FDA approval for that specific indication
- Present animal study results as if they apply directly to humans
- Accept payment from peptide vendors in exchange for favorable content
- Publish health claims without supporting citations from primary literature
- Recommend specific products, brands, or vendors
Corrections Policy
If we discover an error in our content, we correct it promptly and transparently. Significant corrections are noted with an editorial update at the top of the article. Minor corrections (typos, formatting) are made without separate notation.
Readers can report potential errors or suggest updates by contacting our editorial team. We investigate every report and make corrections when warranted.
Contact Us
Questions about our editorial process? Contact our editorial team at editorial@everydaypeptides.com.